Absci Corporation.
ABSI.US | Research and experimental development on natural sciences and engineering
Absci Corporation is a biotechnology company that focuses on AI-powered drug creation. They have developed an Integrated Drug Creation Platform which combines deep learning AI with synthetic biology to design and discover novel biologics. Their platform aims to accelerate drug discovery, improve the...Show More
Better Health for All
60
Absci Corporation's core business is AI-powered drug creation, with its entire portfolio dedicated to developing novel biologics for various diseases, including breast cancer, HIV, inflammatory diseases, dermatological conditions, and immuno-oncology.
1
The company has multiple drug candidates (ABS-101, ABS-201, ABS-301, ABS-501) in preclinical or early clinical stages, with ABS-101 expected to enter Phase 1 clinical trials in the first half of 2025 and ABS-201 in early 2026.
2
There is no evidence of the company generating revenue from products with negative health outcomes.
3
Absci's R&D expenses were $63.9 million in 2024, while its revenue was $4.5 million in the same year, indicating that over 25% of its revenue is allocated to R&D for health improvement.
4
The company is collaborating with Caltech, supported by a grant from the Bill & Melinda Gates Foundation, to develop an affordable and accessible HIV therapeutic vaccine, specifically addressing the cost and inaccessibility of current therapies and aiming to reach low-income and marginalized communities.
5
Absci also received a $20 million equity investment from AMD in January 2025 to enhance its AI drug discovery capabilities.
6
The company expects to submit an Investigational New Drug (IND) application in Q1 2025, approximately two years after program initiation, which is faster than industry standards.
7
Fair Money & Economic Opportunity
0
Absci Corporation is a biotechnology company focused on AI-powered drug creation.
1
Its core business does not involve lending, insuring, moving, or storing money, nor does it offer consumer financial products or services.
2
Therefore, all KPIs related to fair money and economic opportunity, which are designed for financial institutions, are not applicable to Absci's operations.
Fair Pay & Worker Respect
-10
Absci employees rated their overall satisfaction at 3.0 out of 5 stars, based on 58 reviews, as of December 2025.
1
This translates to approximately 60% engagement.
Fair Trade & Ethical Sourcing
0
The provided articles for Absci Corporation (ABSI.US) do not contain specific, quantifiable data points for any of the KPIs under the 'Fair Trade & Ethical Sourcing' value. While Article 1 (SCI Supplier Code of Conduct) outlines expectations for suppliers regarding child labor, forced labor, and ethical conduct, it does not provide evidence of actual performance, audit frequencies, incident numbers, traceability percentages, remediation times, or the percentage of contracts with ethical clauses.
1
Similarly, Article 2 (Code of Business Conduct and Ethics) details internal compliance monitoring but lacks supplier-specific metrics.
2
Therefore, all KPIs must be omitted due to a lack of concrete evidence.
Honest & Fair Business
-40
Absci Corporation has a Code of Business Conduct and Ethics, adopted in July 2021 and amended in December 2023 and September 2025.
1
This Code includes a whistleblower policy that explicitly protects employees' rights to file charges or complaints with government agencies, communicate with them, exercise National Labor Relations Act rights, share compensation information, discuss unlawful acts, and testify truthfully.
2
The company also states it will not limit any right to receive a whistleblower award and provides multiple anonymous reporting channels, including an online portal and a hotline.
3
For anti-corruption, the company states it does not permit or condone bribes, kickbacks, or other improper payments, transfers, or receipts, and has instituted policies and procedures to ensure compliance with anti-bribery and anti-corruption laws.
4
The financial statements of the company and its subsidiaries have been certified by Ernst & Young LLP, an independent registered public accounting firm.
5
Kind to Animals
-10
Absci focuses on AI-driven drug discovery, utilizing computational and high-throughput wet lab methods, including organ-on-a-chip, to reduce animal testing.
1
These alternative methods are standard in their product development. The company is collaborating with Invetx to develop a Half-Life Extension platform for animal health applications, which involves using Absci's AI models to design novel antibody sequences.
2
However, there is no evidence of Absci's participation in multi-stakeholder initiatives to develop industry-wide animal-free testing and sourcing standards.
3
The company's core business model does not involve animal agriculture operations or sourcing.
No War, No Weapons
0
The provided articles focus on Absci Corporation's drug creation pipeline and AI platform, detailing progress on various drug candidates and breakthroughs in HIV vaccine research. The articles explicitly state that no quantitative data or other metrics relevant to the company's involvement in arms or defense contracts, or any other aspects related to the 'No War, No Weapons' value, were mentioned.
1
Planet-Friendly Business
-30
Absci Corporation reported 37% renewable energy usage in 2023, an increase from 28% in 2022.
1
The company has set a carbon neutrality goal for 2030, which is supported by an interim emissions reduction target of 35% by 2025.
2
Respect for Cultures & Communities
0
The provided articles focus on ABSI's financial performance, strategic partnerships, and general diversity and inclusion policy. No specific, quantitative data or concrete actions related to formal partnerships with indigenous or local community groups, community development investments, cultural appropriation incidents, cultural impact assessment protocols, local employment, grievance mechanisms, FPIC processes, community governance, cultural preservation, local procurement, indigenous suppliers, cultural site protection, social license, charitable giving for cultural heritage, community fund allocation, language inclusivity, cultural incident response, or cultural sensitivity training were found.
1
Therefore, no KPIs could be scored against the 'Respect for Cultures & Communities' value.
Safe & Smart Tech
-20
The company states there have been no breaches, violations, outages, or unauthorized uses of or accesses to its IT systems, except for those remedied without material cost or liability or the duty to notify any other person.
1
It also reports no unauthorized access to or processing of Personal Data.
2
The company has an employee cybersecurity awareness training program, including simulated phishing campaigns, provided during onboarding and annually.
3
It has implemented and maintained commercially reasonable controls, policies, procedures, and safeguards to protect confidential information and the integrity and security of IT systems and data.
4
The company states compliance with all applicable federal, state, local, and foreign laws, including HIPAA, CCPA, and GDPR, and has not received any notification or complaint regarding non-compliance with data security obligations.
5
The company engages third parties for annual penetration testing and maintains a third-party managed detection and response (MDR) team, but no specific metrics on coverage or remediation timeframes are provided.
6
Zero Waste & Sustainable Products
-30
Absci Corporation implemented 3 key sustainable research protocols.
1
These initiatives led to a 22% reduction in laboratory waste in 2023, a 45% reduction in physical screening processes, and a 62% reduction in material consumption compared to traditional methods.
2